期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

终末期肾脏病对非瓣膜性心房颤动患者发生卒中及出血事件的影响

下载PDF
导出
摘要 非瓣膜性心房颤动(房颤)是最常见的心律失常,卒中是房颤严重并发症之一。终末期肾脏病(ESRD)与房颤有共同的危险因素。有研究报道,ESRD可通过改变多种生理机制增加房颤患者的卒中及出血风险,并与远期预后相关。抗凝治疗作为房颤患者卒中的一级及二级预防可使患者获益,但如何准确细致地评估房颤伴ESRD患者抗凝治疗的获益和风险仍不明确,多项评价房颤伴ESRD患者抗凝治疗的临床实验结果不尽相同。本文就ESRD对非瓣膜性房颤患者发生卒中与出血事件的影响进行综述。
作者 沈文 吴清华
机构地区 南昌大学第二附属医院心内科
出处 《中国循环杂志》 CSCD 北大核心 2016年第2期192-194,共3页 Chinese Circulation Journal
关键词 综述 心房颤动 肾疾病 血栓形成 出血
分类号 R54 [医药卫生—心血管疾病]
  • 相关文献

参考文献30

  • 1艾克拜尔.安尼瓦尔,李俊红,木拉提.阿不都热合曼.心房颤动治疗的研究新进展[J].中国循环杂志,2014,29(11):955-957. 被引量：17
  • 2Meguid ENA, Bello AK. Chronic kidney disease: the global challenge. Lancet, 2005, 365:331-38-0.
  • 3Bozbas H, Atar I, Yildirir A, et al. Prevalence and predictors of arrhythmia in end stage renal disease patients on hemodialysis. Ren Fail, 2007, 29: 331-339.
  • 4Alonso A, Lopez FL, Matsushita K, et al. Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study. Circulation, 2011, 123: 2946- 2953.
  • 5Soliman EZ, Prineas RJ, Go AS, et al. Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC). Am Heart J, 2010, 159:1102-1107.
  • 6Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation- executive summary: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Managementof Patients With Atrial Fibrillation). J Am Coll Cardiol, 2006, 48: 854- 906.
  • 7Reinecke H, Brand E, Mesters R, et al. Dilemmas in the management of atrial fibrillation in chronic kidney disease. J Am Soc Nephrol, 2009, 20:705-711.
  • 8Capodanno D, Angiolillo DJ. Antithrombotic therapy in patients with chronic kidney disease. Circulation, 2012, 125: 2649-2661.
  • 9Lo DS, Rabbat CG, Clase CM. Thromboembolism and anticoagulant management in hemodialysis patients: a practical guide to clinical management. Thromb Res, 2006, 118: 385-395.
  • 10Seliger SL, Gillen DL, Longstreth WT Jr, et al. Elevated risk of stroke among patients with end-stage renal disease. Kidney Int, 2003, 64: 603 -609.

二级参考文献34

  • 1Mahajan R, Brooks AG, Sullivan T, et al. Importance of the underlying substrate in determining thrombus location in atrial fibrillation: implications for left atrial appendage closure. Heart, 2012, 98:1120-1126. Whitlock RP, Vincent J, Blackall MH, et al. Left Atrial Appendage Occlusion Study II (LAAOS II). Can J Cardiol, 2013, 29: 1443-1447.
  • 2Toumanides S, Sideris EB, Agricola T, et al. Transcatheter patch occlusion of the left atrial appendage using surgical adhesives in high- risk patients with atrial fibrillation. J Am Coil Cardiol, 2011, 58: 2236-2240.
  • 3Bruce CJ, Stanton CM, Asirvatham SJ, et al. Percutaneous epicardial lefl atrial appendage closure: intermediate-term results. J Cardiovasc Electrophysiol, 2011, 22: 64-70.
  • 4Stone D, Byrne T, Pershad A. Early Results With the LARIAT Device for Left Atrial Appendage Exclusion in Patients With Atrial Fibrillation at High Risk for Stroke and Anticoagulation. Catheter Cardiovasc Interv, 2013, doi: 10. 1002. [Epub ahead of print].
  • 5Nakai T, Lesh MD, Gerstenfeld EP, et al. Percutaneous left atrial appendage occlusion (PLAATO) for preventing cardioembolism: first experience in canine model. Circulation, 2002, 105: 2217-2222.
  • 6Ostermayer SH, Reismau M, Kramer PH, et al. Percutaueous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials. J Am Coil Cardiol, 2005, 46: 9-14.
  • 7Ostermayer SH, Reisman M, Kramer PH, et al. Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials. J Am Coil Cardiol, 2005, 46: 9-14.
  • 8Sick PB, Schuler G, Hauptmann KE, et al. Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation. J Am Coil Cardiol, 2007, 49: 1490-1495.
  • 9Holmes DR, Reddy VY, Turi ZG, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet, 2009, 374: 534-542.
  • 10Block PC, Burstein S, Casale PN, et al. Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study. JACC Cardiovasc Interv, 2009, 2: 594-600.

共引文献23

中国循环杂志
2016年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部